🔗 Permalink

Inventor profile of:

Stefan Limmer

City:

Kulmbach

Country:

Germany

Published Applications:

Last publication date:

2018-06-28

Top Assignees for applications by Stefan Limmer

The entities that hold a legal rights for patent applications filed by inventor Limmer Stefan:

ALNYLAM PHARMACEUTICALS, INC. 14 Cambridge, MA United States
Alnylam Pharmaceuticals 2 Cambridge, MA United States
Giuliani International, Ltd. 1 Dublin, Ireland
RIBOPHARMA AG 1 KULMBACH, Germany
Alynylam Pharmaceuticals, Inc. 1 Cambridge, MA United States
Alnylam Pharmacuticals, Inc. 1 Cambridge, MA United States

Recent patent applications by Limmer Stefan

Stefan Limmer from Kulmbach, DE has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2018-06-28

US20180179526A1

Chemistry; metallurgy

Method and Medicament For Inhibiting The Expression of A Given Gene

#2 | 2015-12-10

US20150353937A1

Chemistry; metallurgy

Compositions and methods for inhibiting expression of a target gene

#3 | 2014-08-07

US20140220676A1

Chemistry; metallurgy

Method and medicament for inhibiting the expression of a given gene

#4 | 2014-08-07

US20140220113A1

Chemistry; metallurgy

Method and medicament for inhibiting the expression of a given gene

#5 | 2014-04-17

US20140106450A1

Chemistry; metallurgy

Compositions and methods for inhibiting expression of a target gene

#6 | 2014-02-20

US20140051166A1

Chemistry; metallurgy

Method and medicament for inhibiting the expression of a given gene

#7 | 2013-06-27

US20130164843A1

Chemistry; metallurgy

Method and medicament for inhibiting the expression of a given gene

#8 | 2013-06-27

US20130164366A1

Chemistry; metallurgy

Method and medicament for inhibiting the expression of a given gene

#9 | 2011-08-25

US20110207795A1

Chemistry; metallurgy

SMAD7 INHIBITOR COMPOSITIONS AND USES THEREOF

#10 | 2011-05-12

US20110111493A1

Chemistry; metallurgy

Compositions and methods for inhibiting expression of a target gene

#11 | 2010-11-09

US10384339

Compositions and methods for inhibiting expression of a target gene

#12 | 2010-11-04

US20100280102A1

Chemistry; metallurgy

DOUBLE-STRANDED RIBONUCLEIC ACID WITH INCREASED EFFECTIVENESS IN AN ORGANISM

#13 | 2008-07-31

US20080182981A1

Chemistry; metallurgy

Method and medicament for inhibiting the expression of a given gene

#14 | 2008-07-17

US20080171862A1

Chemistry; metallurgy

Method and medicament for inhibiting the expression of a given gene

#15 | 2008-07-17

US20080171861A1

Chemistry; metallurgy

Method and medicament for inhibiting the expression of a given gene

#16 | 2008-07-10

US20080166800A1

Chemistry; metallurgy

Method and medicament for inhibiting the expression of a given gene

#17 | 2008-03-20

US20080070856A1

Human necessities

MEDICAMENT TO TREAT A FIBROTIC DISEASE

#18 | 2007-11-29

US20070275465A1

Chemistry; metallurgy

Double-stranded ribonucleic acid with increased effectiveness in an organism

#19 | 2006-08-10

US20060178324A1

Chemistry; metallurgy

Lipophilic derivatives of double-stranded ribonucleic acid

#20 | 2005-06-02

US20050119203A1

Chemistry; metallurgy

SMAD7 inhibitors for the treatment of CNS diseases

#21 | 2005-06-02

US20050119202A1

Chemistry; metallurgy

Medicament to treat a fibrotic disease

#22 | 2005-05-12

US20050100907A1

Chemistry; metallurgy

Method and medicament for inhibiting the expression of a given gene

InventorID:

311643 ⎘